Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 3Phase NA 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Gastrointestinal 2Tumor-Agnostic 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 3Pain 1Depression 1Body Weight Changes 1Arthralgia 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Calcium × Breast × Clear all
NCT04067726 2026-03-31

TRIDENT

Washington University School of Medicine

Phase 2 Active not recruiting
210 enrolled
Breast

Breast Neoplasms

NCT00068458 2017-12-19

Survival TRaining for ENhancing Total Health (STRENGTH)

Duke University

Phase 2 Completed
39 enrolled
Breast

Body Weight Changes, Breast Neoplasms, Depression

NCT00416715 2017-07-11

Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer

University of Washington

Phase 2 Completed
100 enrolled 6 charts
Breast

Breast Neoplasms, Pain, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡